HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective Roles of Xijiao Dihuang Tang on Coronary Artery Injury in Kawasaki Disease.

AbstractPURPOSE:
Xijiao Dihuang Tang (XJDHT) is a classical formula of traditional Chinese medicine constituted of Cornu Bubali, Rehmannia glutinosa (Gaertn.) DC., Paeonia lactiflora Pall., and Paeonia suffruticosa Andrews. It was first mentioned in the medical classic "Beiji Qianjin Yaofang" written by Simiao Sun in Tang Dynasty. It shows very strong antipyretic and anticoagulant effects and has been clinically applied to treat various type of blood loss, purple and black spots, heat stroke, and glossitis. Kawasaki disease (KD) is considered as a kind of acute febrile illness in children with systemic vasculitis as the main lesions. The aim of this research is to clarify whether XJDHT can play a protective role in KD.
METHODS:
A mouse model of Candida albicans water-soluble fraction (CAWS)-induced coronary arteritis and a KD cell model with tumor necrosis factor (TNF)-α induction were employed to investigate the potential effect and mechanism of XJDHT on coronary artery injury in KD.
RESULTS:
Data showed that XJDHT remarkably alleviated the coronary artery injury of KD mice, as evidenced by reduced inflammation and downregulated expression of pro-inflammatory cytokines interleukin (IL)-1β and TNF-α. In vitro investigation showed that XJDHT could promote cell proliferation, inhibit cell apoptosis, and improve mitochondrial functions. Subsequent studies demonstrated that XJDHT rescued endothelial cell injury by PI3K/Akt-NFκB signaling pathway. Component analysis of XJDHT detected thirty-eight chemically active ingredients, including paeoniflorin, albiflorin, and paeoniflorigenone, which in in vitro experiments exhibited significant rescue effects on TNF-α-mediated endothelial cell injury.
CONCLUSION:
Our findings demonstrated that XJDHT mitigated coronary artery injury of KD through suppressing endothelial cell damage via PI3K/Akt-NFκB signaling.
AuthorsJian Zhang, Yingzhi Zhuge, Xing Rong, Chao Ni, Chao Niu, Zhengwang Wen, Hongzhou Lin, Maoping Chu, Chang Jia
JournalCardiovascular drugs and therapy (Cardiovasc Drugs Ther) Vol. 37 Issue 2 Pg. 257-270 (04 2023) ISSN: 1573-7241 [Electronic] United States
PMID34665368 (Publication Type: Journal Article)
Copyright© 2021. Springer Science+Business Media, LLC, part of Springer Nature.
Chemical References
  • Tumor Necrosis Factor-alpha
  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • NF-kappa B
Topics
  • Mice
  • Animals
  • Mucocutaneous Lymph Node Syndrome (drug therapy, pathology)
  • Coronary Vessels
  • Tumor Necrosis Factor-alpha (metabolism)
  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • NF-kappa B
  • Coronary Artery Disease
  • Disease Models, Animal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: